Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets
Type 1 diabetes (T1D) is an autoimmune disease caused by the immune system attacking and destroying insulin-producing β cells in the pancreas. Islet transplantation is becoming one of the most promising therapies for T1D patients. However, its clinical use is limited by substantial cell loss after i...
Main Authors: | Yannan Shi, Ying-Zheng Zhao, Zhikai Jiang, Zeqing Wang, Qian Wang, Longfa Kou, Qing Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.923241/full |
Similar Items
-
Multifunctional Islet Transplantation Hydrogel Encapsulating A20 High-Expressing Islets
by: Bai X, et al.
Published: (2020-09-01) -
Islet Encapsulation: New Developments for the Treatment of Type 1 Diabetes
by: Qi Zhang, et al.
Published: (2022-04-01) -
Engineering strategies of islet products for endocrine regeneration
by: Yue Cheng, et al.
Published: (2023-06-01) -
Bilirubin Protects Transplanted Islets by Targeting Ferroptosis
by: Qing Yao, et al.
Published: (2020-06-01) -
Advances in the Use of Biologics and Biomaterials toward the Improvement of Pancreatic Islet Graft Survival in Type 1 Diabetes
by: Michael Yilma Yitayew, et al.
Published: (2024-03-01)